| ∧ ∨ Type | ∧ ∨ Title | Principal Investigators | Status | ∧ ∨ Year |
|---|---|---|---|---|
| H20_RIA - Horizon 2020_Research & Innovation Action/Innovation Action |
Revolutionizing Healthcare by Tracking and Understanding Human Cells during Disease (LifeTime)
|
|
Closed | 2019 |
| H20_RIA - Horizon 2020_Research & Innovation Action/Innovation Action |
Enhanced Delivery Ecosystem for Neurosurgery in 2020
|
|
Closed | 2015 |
| Horizon Europe Global Challenge-RIA/IA/CSA |
The pandemic within: tackling brain vulnerability in COVID19 at high resolution: NEUROCOV
|
|
Ongoing | 2022 |
| INTLI - Finanziamenti internazionali |
Early Detection and Diagnosis of Emerging Biological Threats
|
|
Closed | 2019 |
| INTLI - Finanziamenti internazionali |
Novel approaches of "personalized medicine" as proof of principle for CDKL5 related pathologies
|
|
Closed | 2015 |
| INTLI - Finanziamenti internazionali |
Exploiting computational biology for target identification and drug repositioning in CDKL5 disorder
|
|
Closed | 2016 |
| INTLI - Finanziamenti internazionali |
Neural stem precursor cell therapy: a novel therapeutic approach for the treatment of Rett syndrome
|
|
Closed | 2020 |
| INTLI - Finanziamenti internazionali |
Technologies for Non-Equilibrium Systems (TechNES)
|
|
Ongoing | 2020 |
| INTLI - Finanziamenti internazionali |
Role of glycan chain of ganglioside GM1 in modulating the neuronal signaling
|
|
Closed | 2020 |
| INTLI - Finanziamenti internazionali |
Newly identified PHOX2B-regulated ion channels as possible drug targets for the pharmacological intervention in Congenital Central Hypoventilation Syndrome (CCHS)
|
|
Closed | 2017 |
